Fludarabine Based RIC for Bone Marrow Failure Syndromes | MicrobiomeTrials← Back to trialsNCT02928991
Fludarabine Based RIC for Bone Marrow Failure Syndromes
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2015-04Est. Completion: 2027-12
Enrollment target: 25 participants Locations- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Other microbiome trials you might be interested in
Fanconi AnemiaInherited Bone Marrow Failure Syndrome
Background:
Fanconi anemia (FA) is an inherited disorder. People with FA are more likely to get certain cancers, especi…
Bethesda, United StatesEst. completion Dec 31, 2035
Refractory Acute Myeloid LeukemiaRelapsed Acute Myelomonocytic LeukemiaMyelodysplastic Syndromes
The purpose of this study is to evaluate how effective lower doses of CPX-351 are in older participants with relapsed/re…
Cleveland, United StatesEst. completion Jan 19, 2026
Diamond Blackfan AnemiaDyskeratosis CongenitaFanconi AnemiaShwachman Diamond SyndromeInherited Bone Marrow Failure Syndrome, Aplastic Anemia
Background:
A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regardi…
Bethesda, United States